Home > Insider Trading > Filing (0001062993-15-002354)

Filing Details

Accession Number:: 0001062993-15-002354
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-05-04 17:03:17
Reporting Period:: 2014-11-12

Filing Date:: 2015-05-04
Accepted Time:: 2015-05-04 17:03:17
Original Submission Date:: 2014-11-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875622	Biospecifics Technologies Corp	BSTC	Pharmaceutical Preparations (2834)	113054851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1355189	Thomas Wegman	C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563	President And Chief Executive	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $0.001 Par Value	Disposition	2014-11-12	27,700	$39.08	189,522	No	4	S	Direct
Common Stock, $0.001 Par Value	Disposition	2014-11-13	4,300	$39.04	185,222	No	4	S	Direct
Common Stock, $0.001 Par Value	Disposition	2014-11-14	8,000	$38.50	174,822	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	1,005,178	Indirect	Held by the Edwin H. Wegman Marital Trust
Common Stock, $0.001 Par Value	4,390	Indirect	Held by Jacob Wegman
Common Stock, $0.001 Par Value	3,650	Indirect	Held by Sandra Wegman

Footnotes

The selling price of $39.0771 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares include 8,778 shares held by the reporting person and his wife, Mrs. Sandra Wegman, as joint tenants.
The selling price of $39.0364 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.15. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are held in trust on behalf of the reporting person and Mrs. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
These shares are held in a trust for the benefit of Mr. Jacob Wegman, a minor child residing in the home of the reporting person. The reporting person is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are held by the wife of the reporting person, Ms. Sandra Wegman. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.